Protalix BioTherapeutics Inc (PLX)
1.69
+0.03
(+1.81%)
USD |
NYAM |
Nov 22, 16:00
1.70
+0.01
(+0.59%)
Pre-Market: 20:00
Protalix BioTherapeutics Free Cash Flow: 7.171M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.171M |
| June 30, 2024 | -4.182M |
| March 31, 2024 | 4.369M |
| December 31, 2023 | -2.467M |
| September 30, 2023 | -8.636M |
| June 30, 2023 | -10.56M |
| March 31, 2023 | -22.82M |
| December 31, 2022 | -25.63M |
| September 30, 2022 | -28.34M |
| June 30, 2022 | -21.30M |
| March 31, 2022 | -7.582M |
| December 31, 2021 | -11.74M |
| September 30, 2021 | -14.03M |
| June 30, 2021 | -15.52M |
| March 31, 2021 | -29.80M |
| December 31, 2020 | -26.76M |
| September 30, 2020 | -22.65M |
| June 30, 2020 | -22.56M |
| March 31, 2020 | -19.72M |
| December 31, 2019 | -19.98M |
| September 30, 2019 | -20.46M |
| June 30, 2019 | -3.31M |
| March 31, 2019 | -6.212M |
| December 31, 2018 | -8.428M |
| September 30, 2018 | 13.06M |
| Date | Value |
|---|---|
| June 30, 2018 | -11.15M |
| March 31, 2018 | -11.98M |
| December 31, 2017 | -10.96M |
| September 30, 2017 | -35.72M |
| June 30, 2017 | -28.64M |
| March 31, 2017 | -31.72M |
| December 31, 2016 | -32.95M |
| September 30, 2016 | -29.35M |
| June 30, 2016 | -34.54M |
| March 31, 2016 | -28.10M |
| December 31, 2015 | -24.75M |
| September 30, 2015 | -25.93M |
| June 30, 2015 | -26.94M |
| March 31, 2015 | -27.98M |
| December 31, 2014 | -30.07M |
| September 30, 2014 | -29.99M |
| June 30, 2014 | -28.74M |
| March 31, 2014 | -30.92M |
| December 31, 2013 | -32.54M |
| September 30, 2013 | -26.01M |
| June 30, 2013 | -26.26M |
| March 31, 2013 | -4.57M |
| December 31, 2012 | -1.433M |
| September 30, 2012 | -10.32M |
| June 30, 2012 | -10.65M |
Free Cash Flow Range, Past 5 Years
-29.80M
Minimum
Mar 2021
7.171M
Maximum
Sep 2024
-15.14M
Average
-17.62M
Median
Free Cash Flow Benchmarks
| Accuray Inc | -14.24M |
| Aethlon Medical Inc | -8.905M |
| AIM ImmunoTech Inc | -21.33M |
| Perspective Therapeutics Inc | -40.58M |
| Armata Pharmaceuticals Inc | -42.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.105M |
| Cash from Investing (Quarterly) | 20.33M |
| Cash from Financing (Quarterly) | -20.42M |
| Free Cash Flow Per Share (Quarterly) | 0.0495 |
| Free Cash Flow to Equity (Quarterly) | 24.44M |
| Free Cash Flow to Firm (Quarterly) | 4.143M |
| Free Cash Flow Yield | 5.40% |